GHRL and neurodegenerative disease: However, there might be scenarios where LEAP2 shows no effect or even negative effects, such as lowering appetite during energy deficit or making contributions to the development of neurodegenerative diseases, due to the inhibition of ghrelin properties (Figure 3 and Figure 4).